Study Endpoints
The study’s primary endpoints were the successful deployment of the device and pacing capture in AV sequential synchrony. Safety endpoints included major adverse cardiac events, any cardiac arrhythmia requiring cardioversion, and pericardial effusion with or without associated cardiac tamponade.